Anupam Rasayan India Share Price
1235.10-5.10 (-0.41%)
+11.69% past 1 Year
Anupam Rasayan India Limited is one of the leading companies engaged in the custom synthesis and manufacturing of specialty chemicals in India. Its business verticals are (i) life science related
Corporate filings & documents
Announcements
Submission of Newspaper Advertisement clippings pertaining to Post Offer Advertisement.
2 days agoSubmission of Newspaper Advertisement clippings pertaining to Post Offer Advertisement.
2 days agoThe credit rating agency Crisil Ratings Limited has continued its ratings on the bank facilities and non-convertible debentures of the Company.
3 days agoThe credit rating agency Crisil Ratings Limited has continued its ratings on the bank facilities and non-convertible debentures of the Company.
3 days agoSubmission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
2 weeks agoSubmission of transcript of earnings call on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 14 2026 for Anand Sureshbhai Desai
2 weeks agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on August 14 2026 for Anand Sureshbhai Desai
2 weeks agoSubmission of newspaper advertisement clippings pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026
2 weeks agoSubmission of newspaper advertisement clippings pertaining to the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026
2 weeks agoSubmission of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
2 weeks agoSubmission of Audio Recording of Earnings Call pertaining to the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
2 weeks agoInvestor Presentation regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
3 weeks agoInvestor Presentation regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
3 weeks agoPress Release regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
3 weeks agoPress Release regarding Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
3 weeks agoThe Board of Directors at its meeting held on August 14 2026 has considered and approved the unaudited financial results (standalone & consolidated) of the company for the quarter ended June 30 2026.
3 weeks agoThe Board of Directors at its meeting held on August 14 2026 has considered and approved the unaudited financial results (standalone & consolidated) of the company for the quarter ended June 30 2026.
3 weeks agoThe Board of Directors at its meeting held on August 14 2026 has considered and approved the appointment of Mr. Ravi Desai as Chief Operating Officer of the Company with effect from August 14 2026.
3 weeks agoThe Board of Directors at its meeting held on August 14 2026 has considered and approved the appointment of Mr. Ravi Desai as Chief Operating Officer of the Company with effect from August 14 2026.
3 weeks agoThe Board of Directors at its meeting held today i.e. August 14 2026 has inter-alia considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30 2026.
3 weeks agoThe Board of Directors at its meeting held today i.e. August 14 2026 has inter-alia considered and approved the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended June 30 2026.
3 weeks agoNomination and Remuneration Committee of the Board at its meeting held on August 13 2026 has approved the allotment of 1531 equity shares under ESOP Scheme.
3 weeks agoNomination and Remuneration Committee of the Board at its meeting held on August 13 2026 has approved the allotment of 1531 equity shares under ESOP Scheme.
3 weeks agoIntimation of the Earnings Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 scheduled to be held on Friday August 14 2026 at 02:00 p.m. IST.
3 weeks agoIntimation of the Earnings Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 scheduled to be held on Friday August 14 2026 at 02:00 p.m. IST.
3 weeks agoAnupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026.
3 weeks agoAnupam Rasayan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026.
3 weeks agoSubmission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement
1 month agoSubmission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement
1 month agoSubmission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders by the Company together with PAC
1 month agoSubmission of Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareholders by the Company together with PAC
1 month agoSubmission of copy of newspaper advertisement clippings pertaining to the Addendum to the Public Announcement Detailed Public Statement and Draft Letter of Offer.
1 month agoSubmission of copy of newspaper advertisement clippings pertaining to the Addendum to the Public Announcement Detailed Public Statement and Draft Letter of Offer.
1 month agoAcquisition of shares
1 month agoAcquisition of shares
1 month agoPress Release Intimation titled "Anupam Rasayan signs Letter of Intent with BASQUEVOLT S.A. for the potential long-term supply of a specialty chemical product worth ?300 Mn.
1 month agoPress Release Intimation titled "Anupam Rasayan signs Letter of Intent with BASQUEVOLT S.A. for the potential long-term supply of a specialty chemical product worth ?300 Mn.
1 month agoConfirmation Certificate of Non-Applicability of Reg. 74(5) of SEBI (DP) Regulations.
1 month agoConfirmation Certificate of Non-Applicability of Reg. 74(5) of SEBI (DP) Regulations.
1 month agoThe Trading Window shall remain closed from Wednesday July 01 2026 till the end of 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
2 months agoThe Trading Window shall remain closed from Wednesday July 01 2026 till the end of 48 hours after the declaration of the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026.
2 months agoIntimation of Press Release titled "Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate) using flow chemistry"
2 months agoIntimation of Press Release titled "Anupam Rasayan India Limited becomes the first company in the world to commercialise ETFA (Ethyl trifluoroacetate) using flow chemistry"
2 months agoPursuant to Regulation 30 of the SEBI Listing Regulations please find attached Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday relating to the mandatory open offer by our Company to the public shareholders of Bliss GVS Pharma Limited
2 months agoPursuant to Regulation 30 of the SEBI Listing Regulations please find attached Draft Letter of Offer filed by the Manager to the Offer with SEBI yesterday relating to the mandatory open offer by our Company to the public shareholders of Bliss GVS Pharma Limited
2 months agoIntimation of schedule of Investor Meet to be held on June 09 2026
3 months agoThe credit rating agency India Ratings and Research (Ind-Ra) has updated the credit rating of the Company
3 months agoThe credit rating agency CRISIL Ratings Limited has updated credit rating of the Company.
3 months agoThe credit rating agency CRISIL Ratings Limited has updated credit rating of the Company.
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
Oct 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
Nov 2023
Aug 2023
May 2023
Jan 2023
Oct 2022
ConcallPresentation
Oct 2022
ConcallPresentation
Jul 2022
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2025-07-21
Dividend
0.75
2024-09-17
Dividend
0.75
2023-11-20
Dividend
0.5
2023-05-15
Dividend
1.5
2023-02-08
Dividend
0.6
2022-09-02
Dividend
1.0
2021-11-17
Dividend
0.5
2021-09-15
Dividend
0.5
Company details
Registered office
Office Nos. 1101 To 1107, 11th Floor Icon Rio, Behind Icon Business Centre Surat- Dumas Airport Road Surat Gujarat PIN: 395007 Tel No: 0261-2398991-95 Fax No: 0261-2398996 Email: [email protected] Internet: www.anupamrasayan.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Ashish Gupta, Company Secretary & Compliance Officer
Kiran Chhotubhai Patel, Chairperson
Mona Anandbhai Desai, Vice Chairperson
Anand Sureshbhai Desai, Managing Director
Anuj Hemantbhai Thakar, Whole Time Director
Ketan Desai, Non Executive Independent Director
Madhuri Ajit Sawant, Non Executive Independent Director
Anand Rajeshwarrao Chatorikar, Non Executive Independent Director
Milind Madan Talathi, Non Executive Independent Director
Details
BSE 543275
NSE ANURAS
ISIN INE930P01018